 SARASOTA, Fla., May 10, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on commercializing the worlds only in vivo Intravaginal Culture System IVC, INVOcell, an effective and affordable treatment for patients diagnosed with infertility, is pleased to announce the appointment of tenured womens health fertility solution marketing professional, Meryle Lynn Chamberlain, as Director of Marketing, a newly created position within the company. 